Clinical trial

Exacerbation Study

NCT00845728

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-03-01

PhasePHASE3

Study timeline

Study start (unknown)2009-03-01Date precision: month

Registry last updated2013-11-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

Indacaterol 150 µgDRUG

TiotropiumDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

BerlinGermany7 MoscowRussia7 MontrealQuebec, Canada4 HamburgGermany4 MünchenGermany4 TorontoOntario, Canada3 LondonUnited Kingdom3 Saint PetersburgRussia3 KrakowPoland3 Porto AlegreRio Grande do Sul, Brazil3 LisbonPortugal3 BarcelonaCatalonia, Spain3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00845728 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.